Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease

Violina Kakoty, Sarathlal K C, Sunil Kumar Dubey, Chih Hao Yang, Prashant Kesharwani, Rajeev Taliyan

研究成果: 雜誌貢獻回顧型文獻同行評審

摘要

Continual strategies to devise a complete therapeutic cure for neurodegenerative conditions has been a challenge, majorly due to the presence of blood brain barrier. Lack of targeted delivery in order to minimize loss of dopamine (DA) neurones has been a major challenge to overcome anomalies in Parkinson Disease (PD). PD is a neuromotor degenerative disorder deteriorating motor coordination in affected individuals. Recent research has highlighted the use of lentiviral vectors (LVs) for selective delivery of neuroprotective substance for complete halt of disease progression in PD. LVs have the ability to infect both dividing and non-dividing cells along with non-encoding capability of viral protein that might elicit an immune response. This review will mainly focus on understanding the basic mechanism of action of LVs and its therapeutic aid in PD.
原文英語
文章編號135769
期刊Neuroscience Letters
750
DOIs
出版狀態已發佈 - 四月 17 2021

ASJC Scopus subject areas

  • 神經科學 (全部)

指紋

深入研究「Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease」主題。共同形成了獨特的指紋。

引用此